Accurex Cardiac Troponin 1 Fast
1 Test Kit
Manufacturer
Accurex Biomedical Pvt. Ltd
Accurex Cardiac Troponin 1 Fast is a diagnostic test kit used to measure Cardiac Troponin I (cTnI) levels in serum, plasma, or whole blood to aid in diagnosing Acute Myocardial Infarction (AMI), Unstable Angina, Acute Myocarditis, and Acute Coronary Syndrome (ACS).
Introduction:
Accurex Cardiac Troponin 1 Fast is a highly sensitive and specific in vitro diagnostic test kit designed to detect Cardiac Troponin I (cTnI) in serum, plasma, or whole blood. The test is primarily used to aid in diagnosing Acute Myocardial Infarction (AMI), Unstable Angina, Acute Myocarditis, and Acute Coronary Syndrome (ACS). Clinical studies have demonstrated the release of cTnI into the bloodstream within hours following acute myocardial infarction. Elevated levels of cTnI are probably detected in blood within 4 to 6 hours after the onset of chest pain or angina, reaching their peak concentrations within approximately 8 to 28 hours, and remain elevated for 3 to 10 days following myocardial infarction.
Dosage Form:
Test strip
How to Use:
Collect specimens according to safe phlebotomy procedures. Test card, reagent, and sample should be brought down to room temperature before testing. Confirm that the SD card lot number matches the test kit lot No. Perform SD Card calibration whenever the lot number is changed and when necessary. On the main menu of ACCUDx CQ Analyzer, press the ENT button to enter the testing interface. Remove the test card from the pouch prior to use. Label the test card with patient identification.
How it Works:
The test uses an anti-human cTnI monoclonal antibody conjugated with fluorescence latex and another anti-human cTnI monoclonal antibody coated on the test line. After the sample has been applied to the test strip, the fluorescence latex-labelled anti-human cTnI monoclonal antibody binds with the cTnI in the sample and forms a marked antigen-antibody complex. This complex moves to the test detection zone by capillary action. Then, the marked antigen-antibody complex is captured on the test line by the anti-human cTnI monoclonal antibody. The fluorescence intensity of the test line increases in proportion to the amount of cTnI in the sample.
Introduction:
Accurex Cardiac Troponin 1 Fast is a highly sensitive and specific in vitro diagnostic test kit designed to detect Cardiac Troponin I (cTnI) in serum, plasma, or whole blood. The test is primarily used to aid in diagnosing Acute Myocardial Infarction (AMI), Unstable Angina, Acute Myocarditis, and Acute Coronary Syndrome (ACS). Clinical studies have demonstrated the release of cTnI into the bloodstream within hours following acute myocardial infarction. Elevated levels of cTnI are probably detected in blood within 4 to 6 hours after the onset of chest pain or angina, reaching their peak concentrations within approximately 8 to 28 hours, and remain elevated for 3 to 10 days following myocardial infarction.
Dosage Form:
Test strip
How to Use:
Collect specimens according to safe phlebotomy procedures. Test card, reagent, and sample should be brought down to room temperature before testing. Confirm that the SD card lot number matches the test kit lot No. Perform SD Card calibration whenever the lot number is changed and when necessary. On the main menu of ACCUDx CQ Analyzer, press the ENT button to enter the testing interface. Remove the test card from the pouch prior to use. Label the test card with patient identification.
How it Works:
The test uses an anti-human cTnI monoclonal antibody conjugated with fluorescence latex and another anti-human cTnI monoclonal antibody coated on the test line. After the sample has been applied to the test strip, the fluorescence latex-labelled anti-human cTnI monoclonal antibody binds with the cTnI in the sample and forms a marked antigen-antibody complex. This complex moves to the test detection zone by capillary action. Then, the marked antigen-antibody complex is captured on the test line by the anti-human cTnI monoclonal antibody. The fluorescence intensity of the test line increases in proportion to the amount of cTnI in the sample.
